Pherecydes Pharma logo

Pherecydes Pharma

A biotechnology company developing phage therapies for treating bacterial infections.

5

Funding Rounds

$27.3m

Money raised

Overview

A biotechnology company developing phage therapies for treating bacterial infections.

Funding series

Funding Series Analysis

The company Pherecydes Pharma has raised a total of $10.6m in funding over 5 rounds.

Key Insights:

  • Pherecydes Pharma Series B round, January 2018: $10.6m
  • Pherecydes Pharma Series A Funding Round December 2014: $2.52m
  • Pherecydes Pharma Series B Funding Round January 2018: $10.26m
  • Pherecydes Pharma Venture Funding Round March 2015: $2.78m
  • Pherecydes Pharma Grant January 2012: $1.15m
Pherecydes Pharma logo
Pherecydes Pharma Series B round, January 2018 $10.6m
Pherecydes Pharma logo
Pherecydes Pharma Grant January 2012 $1.15m
Pherecydes Pharma logo
Pherecydes Pharma Series A Funding Round December 2014 $2.52m
Pherecydes Pharma logo
Pherecydes Pharma Venture Funding Round March 2015 $2.78m
Pherecydes Pharma logo
Pherecydes Pharma Series B Funding Round January 2018 $10.26m

Industries

Pherecydes Pharma is active in the following industries:
  • Healthcare
  • Therapeutics
  • Biomedical engineering
  • Biopharmaceutical
  • Microbiome
  • Technology
  • Biology
  • Biotechnology
  • Drug discovery
  • Engineering